1RY0 | A:; B: | STRUCTURE OF PROSTAGLANDIN F SYNTHASE WITH PROSTAGLANDIN D2 |
1RY8 | A:; B: | PROSTAGLANDIN F SYNTHASE COMPLEXED WITH NADPH AND RUTIN |
1S1P | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1S1R | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1S2A | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1S2C | A: | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1XF0 | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) COMPLEXED WITH DELTA4-ANDROSTENE-3,17-DIONE AND NADP |
1ZQ5 | A: | CRYSTAL STRUCTURE OF HUMAN ANDROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEXED WITH A POTENT INHIBITOR EM1404 |
2F38 | A: | CRYSTAL STRUCTURE OF PROSTAGLANDIN F SYNATHASE CONTAINING BIMATOPROST |
2FGB | A: | CRYSTAL STRUCTURE OF HUMAN 17BET A-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEXES WITH PEG AND NADP |
3R43 | A: | AKR1C3 COMPLEXED WITH MEFENAMIC ACID |
3R58 | A: | AKR1C3 COMPLEX WITH NAPROXEN |
3R6I | A: | AKR1C3 COMPLEX WITH MECLOFENAMIC ACID |
3R7M | A: | AKR1C3 COMPLEX WITH SULINDAC |
3R8G | A: | AKR1C3 COMPLEX WITH IBUPROFEN |
3R8H | A: | AKR1C3 COMPLEX WITH ZOMEPIRAC |
3R94 | A: | AKR1C3 COMPLEX WITH FLURBIPROFEN |
3UFY | A: | AKR1C3 COMPLEX WITH R-NAPROXEN |
3UG8 | A: | AKR1C3 COMPLEX WITH INDOMETHACIN AT PH 7.5 |
3UGR | A: | AKR1C3 COMPLEX WITH INDOMETHACIN AT PH 6.8 |
3UWE | A: | AKR1C3 COMPLEXED WITH 3-PHENOXYBENZOIC ACID |
4DBS | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 3'-[(4-NITRONAPHTHALEN-1-YL) AMINO]BENZOIC ACID |
4DBU | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 3-((4 -(TRIFLUOROMETHYL)PHENYL) AMINO)BENZOIC ACID |
4DBW | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) IN COMPLEX WITH NADP+ AND 2'-DESMETHYL-INDOMETHACIN |
4DZ5 | A: | W227F ACTIVE SITE MUTANT OF AKR1C3 |
4FA3 | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH (R)-1-(NAPHTHALEN-2-YLSULFONYL)PIPERIDINE-3-CARBOXYLIC ACID (86) |
4FAL | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH 3-((3,4-DIHYDROISOQUINOLIN-2(1H)-YL)SULFONYL)-N-METHYLBENZAMIDE (80) |
4FAM | A:; B: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH 3-((3,4-DIHYDROISOQUINOLIN-2(1H)-YL)SULFONYL)BENZOIC ACID (17) |
4H7C | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH 1-{4-[(2-METHYL-1-PIPERIDINYL)SULFONYL]PHENYL}-2-PYRROLIDINONE |
4HMN | A: | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEX WITH (4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)(MORPHOLINO) METHANONE (24) |